Lumpinas, Baby Boy .

HRN: 29-12-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/07/2026
06/13/2026
IVT
40mg
Q24H
PSNB (PROM X 52 Hours; Thickly MSAF)
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Bloodstream    Compliance to guidelines: